Quantum computing is beginning to move from labs into commercial deployment, and one of the main ways companies will be able to access this technology is through Quantum-as-a-Service (QaaS) offerings.  Instead of companies investing in costly quantum hardware on-site, the QaaS model would allow them to tap into quantum capabilities via remote access services, much like they would with Software-as-a-Service (SaaS) arrangements. But while the delivery model may be akin to the SaaS model, quantum technology is still in its early stages and has unique hardware and infrastructure related challenges, as further described in a recent Covington blog post

In addition to the points in the original Covington blog post, below are some additional points to consider when negotiating QaaS agreements:

1. SLAs:  Expectations around Service Level Agreements (SLAs) may prove to be another thorny area in QaaS contracting. While customers may seek to apply traditional SaaS uptime standards (e.g., 99.9% availability), quantum computing systems may not yet be capable of delivering such high levels of availability.  As such, there may be a push in QaaS contracting for more shared risk around the infrastructural and environmental challenges that are unique to quantum computing.

2. Support Obligations: Support obligations would deviate from what we typically see in the context of SaaS agreements; instead support obligations in quantum will include hardware-related support.

3. Pricing:  Customers may look for predictable pricing and request that the pricing decrease as quantum systems mature and become less expensive to operate. On the other hand, service providers are likely to push for flexibility to raise prices, given the significant uncertainties and expenses associated with maintaining hardware that is so cost-intensive and space-intensive. 

4. Cybersecurity Risks in Hybrid Systems:  Cybersecurity remains a risk when it comes to hybrid systems in quantum computing offerings – although QaaS providers may use quantum computers as the hardware, it is expected that such providers may still make use of classical computing systems for storage and processing of customer data.  Because the classical computing systems that QaaS providers use could be using current encryption standards (such as RSA or ECC), customers may reasonably worry about long-term exposure of their sensitive data once it is shared with and stored by the QaaS service provider in their classical systems. For this reason, customers may press providers to adopt post-quantum or quantum-safe cryptography standards for components that use classical computing, or at least to commit to a roadmap for doing so after the relevant standards, guidance, and best practices are in effect. Service providers, however, may resist any firm obligations given that quantum-safe approaches are still evolving and can introduce interoperability or performance issues. Relatedly, given the unique risks here, customers may seek tighter incident response terms and audit rights.

5. Export Controls: Both service providers and customers will want to be attentive to export controls applicable to the hardware, software, and related technology used to deliver the QaaS offering, as well to any export controls applicable to technologies developed using QaaS.  Even domestic access to a system by a foreign national can constitute an export. Service providers may seek assurances from customers regarding the access and end use of the technologies or data produced using QaaS and may need to limit access to export controlled infrastructure.  Service providers may also request exit provisions in the event customers become subject to export restrictions in the future. Customers may seek to restrict the geographies in which their data is stored or request assurances that the infrastructure used to provide the QaaS is compliant with U.S. export control laws and regulations. 

The above considerations establish that QaaS agreements present issues and considerations that differ from SaaS or other technology services contracts. Given that quantum computing is both technically complex and rapidly evolving, careful drafting that reflects a practical understanding of the underlying technology and its capabilities will be critical. In certain cases, parties may also consider vested contracting, which is a collaborative contracting framework where parties align on shared goals and outcomes.  By anticipating the pace of innovation and embedding flexibility into contractual terms, parties can work towards ensuring that their QaaS agreements remain both effective and sustainable as the technology and field continues to mature.

Another general issue in QaaS contracting centers around appropriately allocating evolving compliance costs and risks. Because legal and regulatory frameworks for quantum computing are still developing (e.g., cybersecurity standards and export controls, as described above), ensuring the service provider’s compliance with established standards will require ongoing consideration, investment, and adaptation. Contracting parties should therefore clarify who bears the related costs and obligations, and consider mechanisms such as cost-sharing provisions or governance committees that are tasked with revisiting and establishing compliance requirements as they evolve. In this regard, the collaborative nature of vested contracting can also prove beneficial, allowing the parties to treat regulatory adaptation as a shared challenge and overall outcome rather than a unilateral burden.

Please feel free to reach out to the authors with any questions.  We would be happy to further discuss this guidance or provide legal support on your next quantum computing project.

Lisa Ann Johnson contributed to the “Export Controls” section of this blog post.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Nigel Howard Nigel Howard

For over 30 years Nigel Howard has specialized in technology transactions such as M&A, strategic alliances, licensing, distribution agreements and outsourcing. Clients range from start-ups and emerging companies to international corporations. He has led negotiations of billion dollar service agreements that were critical…

For over 30 years Nigel Howard has specialized in technology transactions such as M&A, strategic alliances, licensing, distribution agreements and outsourcing. Clients range from start-ups and emerging companies to international corporations. He has led negotiations of billion dollar service agreements that were critical to his client, and successfully handled the intellectual property and data issues on over 250 venture capital and M&A transactions.

Nigel is a “tremendous attorney” singled out for his detail-oriented approach, according to clients interviewed by Chambers and Partners. Peer commentators note his admirable commercial awareness, which achieves business-focused results, often in the most challenging of circumstances. He uses his extensive experience with IP and technology to advise on the commercial imperatives underlying these agreements.

Nigel has been ranked by Chambers Global, Chambers USA, Legal 500, Best Lawyers in America, and Who’s Who in American Law. He is frequent speaker on AI, data, distribution, and technology legal issues. His past and current clients include American Airlines, the American Bankers Association, American Express, AstraZeneca, British Airways, Brown Brothers Harriman, Cathay Pacific, Cisco, CoBank, DoubleClick, Etihad, HPE, Farelogix, Iberia, Mars, Merck, Merrill Lynch, Microsoft, NCR, the NFL, Novartis, P&G, Philippine Airlines, Promontory Financial, Singapore Airlines, Teva, TouchTunes, UBS, and Wyeth.

Photo of Nira Pandya Nira Pandya

Nira Pandya is a member of the firm’s Technology and IP Transactions Practice Group based in Boston.

Nira advises clients on a broad range of complex commercial transactions and strategic collaborations involving technology, intellectual property, and data.

As part of the firm’s Digital…

Nira Pandya is a member of the firm’s Technology and IP Transactions Practice Group based in Boston.

Nira advises clients on a broad range of complex commercial transactions and strategic collaborations involving technology, intellectual property, and data.

As part of the firm’s Digital Health Initiative, Nira advises pharmaceutical, medical device, healthcare, and technology companies on the intellectual property and commercial considerations in collaborations and other transactions at the intersection of life sciences and technology. Her experience spans AI-enabled drug discovery and other data and tech-driven collaborations. Nira also co-leads Covington’s quantum computing initiative.

Nira is focused on delivering practical, business-aligned legal guidance — a key aspect of her approach developed during a secondment with a leading technology company. Earlier in her career, she advised startups and private/public companies on growth, funding, M&A, and other corporate matters, broadening her transactional perspective.

Watch: Nira provides insights on the Life Sciences Industry, as part of our Quantum Computing video series.